Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on β-blockers
Author:
Publisher
Elsevier BV
Subject
Ophthalmology
Reference28 articles.
1. Shortterm “escape” and longterm “drift.” The dissipation effects of the beta adrenergic blocking agents;Boger;Surv Ophthalmol,1983
2. Comparative data for all countries;Kobelt,1998
3. A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group;Schuman;Arch Ophthalmol,1997
4. Twelve-month results of an ongoing randomized trial comparing brimonidine tartrate 0.2% and timolol 0.5% given twice daily in patients with glaucoma or ocular hypertension. Brimonidine Study Group 2;LeBlanc;Ophthalmology,1998
5. Brimonidine tartrate 0.2% twice daily vs timolol 0.5% twice daily;Katz;Am J Ophthalmol,1999
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacogenetics and pharmacogenomics in glaucoma therapeutics: the way to personalized therapy;Chinese Medical Journal;2022-11-30
2. Management of open‐angle glaucoma by primary eye‐care practitioners: toward a personalised medicine approach;Clinical and Experimental Optometry;2021-03-29
3. Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization;Journal of Ocular Pharmacology and Therapeutics;2017-10
4. A review of the use of latanoprost for glaucoma since its launch;Expert Opinion on Pharmacotherapy;2012-02-21
5. Update on the role of alpha-agonists in glaucoma management;Experimental Eye Research;2011-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3